Non-small Cell Lung Cancer with EGFR or HER2 Exon 20 Insertion Mutations: Diagnosis and Treatment Options

Molecular testing is performed upon diagnosis of non-small cell lung cancer (NSCLC) because of the large success of targeted therapies for oncogenic mutations. Epidermal growth factor receptor (EGFR) mutations are the most commonly identified mutation in NSCLC, and EGFR exon 20 insertion mutations (...

Descripción completa

Detalles Bibliográficos
Autores principales: Brazel, Danielle, Kroening, Gianna, Nagasaka, Misako
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649507/
https://www.ncbi.nlm.nih.gov/pubmed/36255589
http://dx.doi.org/10.1007/s40259-022-00556-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649507/
https://www.ncbi.nlm.nih.gov/pubmed/36255589
http://dx.doi.org/10.1007/s40259-022-00556-4

Ejemplares similares